Do pathological parameters of primary tumor correlate with overall survival (OS) of metastatic clear-cell renal cell carcinoma (ccRCC)?

被引:0
|
作者
Basso, Umberto
Maruzzo, Marco
Fraccon, Anna Paola
Sava, Teodoro
Massari, Francesco
Sacco, Cosimo
Valcamonico, Francesca
Maines, Francesca
Lo Re, Giovanni
Donati, Donatella
Baier, Susanne
Durante, Emilia
Soraru', Mariella
Nicodemo, Maurizio
Bearz, Alessandra
Sartori, Donata
Fiduccia, Pasquale
Zustovich, Fable
Pasini, Felice
Zagonel, Vittorina
机构
[1] IRCCS, IOV, Dept Clin & Expt Oncol, Med Oncol 1, Padua, Italy
[2] Casa Cura Pederzoli, Peschiera Del Garda, Italy
[3] Azienda Osped Univ Integrata Verona, Verona, Italy
[4] Univ Verona, Azienda Osped Univ Integrata, Med Oncol, I-37100 Verona, Italy
[5] Azienda Osped Univ, Dipartimento Oncol, Udine, Italy
[6] Univ Brescia, Dept Med & Surg Specialties Radiol Sci & Publ Hlt, Oncol Unit, Brescia, Italy
[7] Santa Chiara Hosp, Trento, Italy
[8] Santa Maria Degli Angeli Gen Hosp, Pordenone, Italy
[9] Oncol Med Osped, Ferrara, Italy
[10] Cent Reg Hosp, Div Med Oncol, Bolzano, Italy
[11] Dept Med Oncol, Legnago, Italy
[12] ULSS 15, Camposampiero, Italy
[13] Sacro Cuore Don Calabria Hosp, Negrar, Italy
[14] IRCCS Ctr Rif Oncol, Pordenone, Italy
[15] Azienda ULSS 13, Mirano, Italy
[16] IRCCS, Ist Oncol Veneto, Unita Sperimentaz Clin & Biostat, Padua, Italy
[17] Osped S Maria Misericordia, ULSS 18, Dept Oncol, Rovigo, Italy
[18] IRCCS, Ist Oncol Veneto, UOC Oncol Med 1, Dipartimento Oncol Clin & Sperimentale, Padua, Italy
关键词
D O I
10.1200/jco.2016.34.2_suppl.549
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
549
引用
收藏
页数:2
相关论文
共 50 条
  • [31] Overall survival, efficacy, and safety outcomes beyond front-line modern therapies in metastatic clear-cell renal cell carcinoma.
    Kreutzfeldt, Jordyn
    Obeng-Kusi, Mavis
    Estrada-Mendizabal, Ricardo J.
    Choi, Briana M.
    Abraham, Ivo
    Recio-Boiles, Alejandro
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41
  • [32] High expression of galectin-7 associates with poor overall survival in patients with non-metastatic clear-cell renal cell carcinoma
    Wang, Jieti
    Liu, Yidong
    Yang, Yuanfeng
    Xu, Zhiying
    Zhang, Guodong
    Liu, Zheng
    Fu, Hangcheng
    Wang, Zewei
    Liu, Haiou
    Xu, Jiejie
    ONCOTARGET, 2016, 7 (27) : 41986 - 41995
  • [33] The two glycolytic markers GLUT1 and MCT1 correlate with tumor grade and survival in clear-cell renal cell carcinoma
    Ambrosetti, Damien
    Dufies, Maeva
    Dadone, Berengere
    Durand, Matthieu
    Borchiellini, Delphine
    Amiel, Jean
    Pouyssegur, Jacques
    Rioux-Leclercq, Nathalie
    Pages, Gilles
    Burel-Vandenbos, Fanny
    Mazure, Nathalie M.
    PLOS ONE, 2018, 13 (02):
  • [34] A moncentric review of targeted therapy on overall survival in metastatic renal clear cell carcinoma
    Tadj, Melanie
    Arnoux, Valentin
    Mousseau, Mireille
    Descotes, Jean Luc
    Quesada, Jean-Louis
    Bensaadi, Lamia
    Laramas, Mathieu
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [35] Glutaminase Inhibitors-Do They Have a Role in the Treatment of Metastatic Clear-Cell Renal Cell Carcinoma? Comment
    Brown, Janet E.
    JAMA ONCOLOGY, 2022, 8 (10) : 1418 - 1419
  • [36] Identification of genomic aberrations associated with overall survival in metastatic clear cell renal cell carcinoma (mccRCC)
    Kessel, Adam
    Tran, Summer
    Rivers, Zachary
    Hahn, Andrew W.
    Nussenzveig, Roberto
    Rathi, Nityam
    Maughan, Benjamin Louis
    Sirohi, Deepika
    Stenehjem, David D.
    Agarwal, Neeraj
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (06)
  • [37] Metastatic adrenal tumor from clear-cell renal cell carcinoma: a pitfall of chemical shift MR imaging
    K. Shinozaki
    K. Yoshimitsu
    H. Honda
    T. Kuroiwa
    H. Irie
    H. Aibe
    S. Naito
    T. Migita
    Y. Asayama
    K. Masuda
    Abdominal Imaging, 2001, 26 : 439 - 442
  • [38] The lipid metabolome of clear cell renal cell carcinoma (CCRCC).
    George, Saby
    Choi, Kyoung-Soo
    Pili, Roberto
    Kazim, Abdul Latif
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [39] DNA methylation status defines clinicopathological parameters including survival for patients with clear cell renal cell carcinoma (ccRCC)
    Evelonn, Emma Andersson
    Degerman, Sofie
    Kohn, Linda
    Landfors, Mattias
    Ljungberg, Borje
    Roos, Goran
    TUMOR BIOLOGY, 2016, 37 (08) : 10219 - 10228
  • [40] Metastatic adrenal tumor from clear-cell renal cell carcinoma: a pitfall of chemical shift MR imaging
    Shinozaki, K
    Yoshimitsu, K
    Honda, H
    Kuroiwa, T
    Irie, H
    Aibe, H
    Naito, S
    Migita, T
    Asayama, Y
    Masuda, K
    ABDOMINAL IMAGING, 2001, 26 (04): : 439 - 442